Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

First-Time Generics - February 2009

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS, 45 MG (BASE), 90 MG (BASE) AND 135 MG (BASE)      IMPAX LABORATORIES, INC. SOLODYN TABLETS 2/3/2009 
2 SUMATRIPTAN SUCCINATE INJECTION, 4 MG (BASE)/0.5 ML AND 6 MG (BASE)/0.5 ML; SINGLE-DOSE VIALS      SANDOZ CANADA, INC. IMITREX INJECTION, SINGLE DOSE VIALS 2/6/2009 
3 SUMATRIPTAN SUCCINATE INJECTION, 6 MG (BASE)/0.5 ML; SINGLE-DOSE VIALS       BEDFORD LABORATORIES IMITREX INJECTION, 6 MG (BASE)/0.5 ML 2/6/2009 
4 SUMATRIPTAN SUCCINATE INJECTION, 6 MG (BASE)/0.5 ML; SINGLE-DOSE VIALS       TEVA PARENTERAL MEDICINES IMITREX INJECTION, 6 MG (BASE)/0.5 ML 2/6/2009 
5 SUMATRIPTAN SUCCINATE INJECTION (SYRINGE), 4 MG (BASE)/0.5 ML AND 6 MG (BASE)/0.5 ML; PRE-FILLED SYRINGES      TEVA PARENTERAL MEDICINES IMITREX INJECTION, 8 MG/ML, 12 MG/ML SYRINGE 2/6/2009 
6 SUMATRIPTAN SUCCINATE TABLETS, 25 MG (BASE), 50 MG (BASE) AND 100 MG (BASE)      TEVA PHARMACEUTICALS USA IMITREX TABLETS 2/9/2009 
7 SUMATRIPTAN SUCCINATE TABLETS, 100 MG        RANBAXY LABORATORIES LIMITED IMITREX TABLETS 2/9/2009 
8 RISPERIDONE ORALLY DISINTEGRATING TABLETS, 0.5 MG AND 2 MG       DR. REDDY'S LABORATORIES LIMITED RISPERDAL M-TAB (ORALLY DISINTEGRATING TABLET 2/24/2009 
-
-